Delivery Order SPE2DB20D3303-SPE2DB24FA1MM

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Clonidine Hydrochloride Extended-Release 0.1 mg tablets. The contract is a Firm Fixed Price Delivery Order valued at $2,027.41, with an ultimate completion date of October 16, 2024. No set-aside designation was used for this award. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
This contract award, with ID SPE2DB20D2014|SPE2DB25FA95G, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of clonidine hydrochloride extended-release 0.1 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,519.08 and a period of performance ending on February 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,085.27 firm-fixed-price delivery order is for the supply of 60-count clonidine hydrochloride extended-release 0.1 mg tablets. The contract has an ultimate completion date of January 4, 2024 and was awarded on January 3, 2024. No set-aside designation was used for this procurement. Amerisourcebergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $4,806.91 firm fixed-price contract is for the provision of clonidine hydrochloride extended-release 0.1 mg tablets. The award is not associated with a set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,528.37 delivery order contract is for the supply of Clonidine HCL ER 0.1 mg tablets to support military healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of January 27, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,139.57 firm-fixed-price delivery order is for the supply of clonidine hydrochloride extended-release 0.1 milligram tablets. The contract has an ultimate completion date of August 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Clonidine Hydrochloride Extended-Release 0.1 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and a Ceiling Value of $22,348.87. The award date is September 16, 2024, and the ultimate completion date is September 17, 2024. This contract is not designated as a set-aside. As a large...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,563,515,852 units of Clonidine HCL ER 0.1 mg Tablets in 60-count packages. The contract has a ceiling value of $2,293.67 and is a Firm Fixed Price Delivery Order with a completion date of February 2, 2024. The contract is not set aside for any specific business category. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,040.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clonidine HCL ER 0.1 mg tablets, a medication used in the treatment of various medical conditions. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $1,078.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of clonidine hydrochloride extended-release 0.17 mg tablets in 30-count packages. The contract has an ultimate completion date of May 8, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp, a subsidiary of the larger Amerisourcebergen Corporation, is a major supplier of pharmaceutical...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA1MM
    Delivery Order

This federal contract award is a delivery order made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of clonidine hydrochloride extended-release 0.17 mg tablets in 30-count packages. The award is valued at $1,089.14 and has a performance period that extends to July 29, 2024. This contract is a firm fixed-price delivery order awarded under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. As a pharmaceutical supplier, Amerisourcebergen leverages its extensive supply chain network to deliver critical medications and medical supplies to various government agencies and healthcare programs, including the military. This contract award does not have a set-aside designation.

Generated 10/25/24, 9:39 AM